Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3671)
All Articles published online
|
Nov 21, 2008 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kawaratani H, Tsujimoto T, Kitazawa T, Kitade M, Yoshiji H, Uemura M, Fukui H. Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet. World J Gastroenterol 2008; 14(43): 6655-6661 [PMID: 19034968 DOI: 10.3748/wjg.14.6655] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i43/6655.htm |
| Number | Citing Articles |
| 1 |
Tea Lund Laursen, Anders Mellemkjær, Holger Jon Møller, Henning Grønbæk, Konstantin Kazankov. Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 2022; 26(8): 697 doi: 10.1080/14728222.2022.2132145
|
| 2 |
Pedro Pimentel-Nunes, João Bruno Soares, Roberto Roncon-Albuquerque Jr, Mário Dinis-Ribeiro, Adelino F Leite-Moreira. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opinion on Therapeutic Targets 2010; 14(4): 347 doi: 10.1517/14728221003642027
|
| 3 |
Koichi Tsuneyama, Hayato Baba, Kentaro Kikuchi, Takeshi Nishida, Kazuhiro Nomoto, Shinichi Hayashi, Shigeharu Miwa, Takahiko Nakajima, Yuko Nakanishi, Shinji Masuda, Mitsuhiro Terada, Johji Imura, Carlo Selmi. Autoimmune Features in Metabolic Liver Disease: A Single-Center Experience and Review of the Literature. Clinical Reviews in Allergy & Immunology 2013; 45(1): 143 doi: 10.1007/s12016-013-8383-x
|
| 4 |
Tatsuyuki Tonan, Kiminori Fujimoto, Aliya Qayyum, Yasuyo Morita, Osamu Nakashima, Noriyuki Ono, Akihiko Kawahara, Masayoshi Kage, Naofumi Hayabuchi, Takato Ueno. CD14 expression and Kupffer cell dysfunction in non‐alcoholic steatohepatitis: Superparamagnetic iron oxide‐magnetic resonance image and pathologic correlation. Journal of Gastroenterology and Hepatology 2012; 27(4): 789 doi: 10.1111/j.1440-1746.2011.07057.x
|
| 5 |
Da Zhou, Jian-Gao Fan. Microbial metabolites in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2019; 25(17): 2019-2028 doi: 10.3748/wjg.v25.i17.2019
|
| 6 |
Tatsuhiro Tsujimoto, Hideto Kawaratani, Toshiyuki Kitazawa, Masahito Uemura, Hiroshi Fukui. Innate Immune Reactivity of the Ileum–Liver Axis in Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2012; 57(5): 1144 doi: 10.1007/s10620-012-2073-z
|
| 7 |
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms 2015; 3(4): 759 doi: 10.3390/microorganisms3040759
|
| 8 |
Pei Wu, Jun Jiang, Yang Liu, Kai Hu, Wei-Dan Jiang, Shu-Hong Li, Lin Feng, Xiao-Qiu Zhou. Dietary choline modulates immune responses, and gene expressions of TOR and eIF4E-binding protein2 in immune organs of juvenile Jian carp (Cyprinus carpio var. Jian). Fish & Shellfish Immunology 2013; 35(3): 697 doi: 10.1016/j.fsi.2013.05.030
|
| 9 |
H. Han, M. Cui, X. You, M. Chen, X. Piao, G. Jin. A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet. Nutrition, Metabolism and Cardiovascular Diseases 2015; 25(6): 556 doi: 10.1016/j.numecd.2015.02.011
|
| 10 |
Giovanni Tarantino, Vincenzo Citro. What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02031-1
|
| 11 |
Chien-Yu Lin, Evanthia Omoscharka, Yanli Liu, Kun Cheng. Establishment of a Rat Model of Alcoholic Liver Fibrosis with Simulated Human Drinking Patterns and Low-Dose Chemical Stimulation. Biomolecules 2023; 13(9): 1293 doi: 10.3390/biom13091293
|
| 12 |
Shuhei Sakaguchi, Shougo Takahashi, Takamitsu Sasaki, Takeshi Kumagai, Kiyoshi Nagata. Progression of Alcoholic and Non-alcoholic Steatohepatitis: Common Metabolic Aspects of Innate Immune System and Oxidative Stress. Drug Metabolism and Pharmacokinetics 2011; 26(1): 30 doi: 10.2133/dmpk.DMPK-10-RV-087
|
| 13 |
Rieko Shimozono, Kazumi Nishimura, Hideo Akiyama, Saeko Funamoto, Akiko Izawa, Takafumi Sai, Kana Kunita, Mie Kainoh, Tomohiko Suzuki, Norifumi Kawada. Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model. Journal of Interferon & Cytokine Research 2015; 35(6): 464 doi: 10.1089/jir.2014.0096
|
| 14 |
Keisuke Nakanishi, Kosuke Kaji, Mitsuteru Kitade, Takuya Kubo, Masanori Furukawa, Soichiro Saikawa, Naotaka Shimozato, Shinya Sato, Kenichiro Seki, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Hitoshi Yoshiji. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. International Journal of Molecular Sciences 2019; 20(11): 2724 doi: 10.3390/ijms20112724
|
| 15 |
Hideto Kawaratani, Tatsuhiro Tsujimoto, Akitoshi Douhara, Hiroaki Takaya, Kei Moriya, Tadashi Namisaki, Ryuichi Noguchi, Hitoshi Yoshiji, Masao Fujimoto, Hiroshi Fukui. The Effect of Inflammatory Cytokines in Alcoholic Liver Disease. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/495156
|
| 16 |
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases 2019; 7(4): 58 doi: 10.3390/diseases7040058
|
| 17 |
Rui Wang, Ruqi Tang, Bo Li, Xiong Ma, Bernd Schnabl, Herbert Tilg. Gut microbiome, liver immunology, and liver diseases. Cellular & Molecular Immunology 2021; 18(1): 4 doi: 10.1038/s41423-020-00592-6
|
| 18 |
Marten Heeringa, Ann Hastings, Shunji Yamazaki, Paul de Koning. Serum Biomarkers in Nonalcoholic Steatohepatitis: Value for Assessing Drug Effects?. Biomarkers in Medicine 2012; 6(6): 743 doi: 10.2217/bmm.12.87
|
| 19 |
Yusaku Shirai, Hitoshi Yoshiji, Ryuichi Noguchi, Kosuke Kaji, Yosuke Aihara, Akitoshi Douhara, Kei Moriya, Tadashi Namisaki, Hideto Kawaratani, Hiroshi Fukui. Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 2013; 28(4): 723 doi: 10.1111/jgh.12112
|
| 20 |
Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Masakazu Uejima, Mitsuteru Kitade, Kousuke Takeda, Yasushi Okura, Kousuke Kaji, Hiroaki Takaya, Norihisa Nishimura, Shinya Sato, Yasuhiko Sawada, Kenichiro Seki, Takuya Kubo, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review). International Journal of Molecular Medicine 2017; 40(2): 263 doi: 10.3892/ijmm.2017.3015
|
| 21 |
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong-Joon Kim, Ki-Tae Suk. Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines 2022; 10(3): 550 doi: 10.3390/biomedicines10030550
|
| 22 |
Tatsuhiro Tsujimoto, Hideto Kawaratani, Toshiyuki Kitazawa, Hitoshi Yoshiji, Masao Fujimoto, Masahito Uemura, Hiroshi Fukui. Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. World Journal of Gastroenterology 2009; 15(44): 5533-5540 doi: 10.3748/wjg.15.5533
|
| 23 |
Y. TORINIWA, M. MURAMATSU, Y. ISHII, E. RIYA, K. MIYAJIMA, S. OHSHIDA, K. KITATANI, S. TAKEKOSHI, T. MATSUI, S. KUME, T. YAMADA, T. OHTA. Pathophysiological Characteristics of Non-Alcoholic Steatohepatitis-Like Changes in Cholesterol-Loaded Type 2 Diabetic Rats. Physiological Research 2018; : 601 doi: 10.33549/physiolres.933784
|
| 24 |
Shiwei Liu, Ruixue Duan, Yaru Wu, Fang Du, Jiaxin Zhang, Xin Li, Shenghui Guo, Meimei Wang, Qi Zhang, Yuanbin Li, Naishi Li. Effects of Vaspin on Insulin Resistance in Rats and Underlying Mechanisms. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31923-3
|
| 25 |
Waleska Dornas, Vincent Lagente. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Pharmacological Research 2019; 141: 418 doi: 10.1016/j.phrs.2019.01.026
|
| 26 |
Hideto Kawaratani, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui. Therapeutic effects of cytokine modulator Y‐40138 in the rat alcoholic liver disease model. Journal of Gastroenterology and Hepatology 2011; 26(4): 775 doi: 10.1111/j.1440-1746.2011.06658.x
|
| 27 |
Yukihisa Fujinaga, Hideto Kawaratani, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Masanori Furukawa, Koh Kitagawa, Shinya Sato, Norihisa Nishimura, Yasuhiko Sawada, Hiroaki Takaya, Kosuke Kaji, Naotaka Shimozato, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(15): 5589 doi: 10.3390/ijms21155589
|
| 28 |
Konstantin Kazankov, Simon Mark Dahl Jørgensen, Karen Louise Thomsen, Holger Jon Møller, Hendrik Vilstrup, Jacob George, Detlef Schuppan, Henning Grønbæk. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nature Reviews Gastroenterology & Hepatology 2019; 16(3): 145 doi: 10.1038/s41575-018-0082-x
|
| 29 |
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
|